跳至主要内容
临床试验/NCT05950035
NCT05950035已完成不适用

An Efficient Treatment for Posttraumatic Injury for Firefighters

Palo Alto Veterans Institute for Research2 个研究点 分布在 1 个国家目标入组 49 人开始时间: 2023年12月1日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
49
试验地点
2
主要终点
Structured Clinical Interview for DSM-5 Sleep Disorders- Revised (SCISD-R)

研究概览

简要总结

The goal of this two-arm pilot randomized controlled trial is to test a behavioral intervention that integrates three evidence-based cognitive behavioral interventions (written exposure therapy; WET, cognitive behavioral therapy for insomnia; CBT-I, and cognitive behavioral therapy for nightmares; CBT-N) among firefighters. The main questions it aims to answer are:

  • Is the behavioral intervention feasible, acceptable, and effective in reducing symptoms of posttraumatic stress, insomnia, and nightmares?
  • What is the efficacy of efficient treatment vs. delayed treatment (2-4 week waitlist) in reducing symptoms of posttraumatic stress, insomnia, and nightmares?

We will beta test the intervention in 1-2 groups of 3-5 firefighters. Then we will randomize 50 participants to immediate or delayed (2-4 week waitlist) treatment. Consented participants will:

  • Complete self-report and interview measures assessing posttraumatic stress disorder, insomnia (PTSD), and nightmares
  • Attend an individual treatment orientation session
  • Attend a 4-day (~3 hours per day over 4 consecutive days) group treatment that integrates WET, CBT-I, and CBT-N
  • Attend an individual booster session held approximately one week later
  • Complete self-report measures before, during, and after treatment, and at a 3-month follow up assessment and a clinical interview before and after treatment to assess program efficacy.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Single (Outcomes Assessor)

入排标准

年龄范围
18 Years 至 65 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • 18-65 years old
  • Firefighter
  • Able to speak and read English
  • Clinically significant posttraumatic stress symptoms: CAPS-5 total score ≥ 25; ≥ 1 intrusion symptom; ≥ 1 avoidance symptom
  • Clinically significant symptoms of insomnia: SCISD insomnia criteria are met; ISI ≥ 15
  • Clinically significant symptoms of nightmare disorder: SCISD nightmare disorder criteria are met, nightmares ≥ 1 monthly.

排除标准

  • Current suicide or homicide risk meriting crisis intervention
  • Inability to speak and read English
  • Inability to comprehend the baseline screening questionnaires
  • Unwilling to remain abstinent from alcohol during treatment
  • Serious mental health diagnosis such as bipolar disorder or psychosis.

结局指标

主要结局

Structured Clinical Interview for DSM-5 Sleep Disorders- Revised (SCISD-R)

时间窗: Change from baseline to post treatment (~4 weeks post baseline)

The SCISD-R is a semi-structured interview designed to obtain a sleep history and screen for certain sleep disorders and diagnose others, including insomnia, hypersomnia, circadian rhythm sleep-wake disorders, sleep-disordered breathing, and parasomnias.

Insomnia Severity Index (ISI)

时间窗: Change from baseline through 3 months post treatment

The ISI assesses perceived severity of insomnia.

Nightmare Disorders Index

时间窗: Change from baseline through 3 months post treatment

The NDI is a self-report assessment of nightmare disorder.

Clinician Administered PTSD Scale (CAPS-5)

时间窗: Change from baseline to post treatment (~4 weeks post baseline)

The CAPS-5 is a structured clinical interview that assesses the presence and severity of PTSD symptoms.

Posttraumatic Stress Disorder Checklist (PCL-5)

时间窗: Change from baseline through 3 months post treatment

Self-report measure update of the PCL designed to assess PTSD symptoms as defined by the DSM-5.

次要结局

  • Sleep Diary and Nightmare Log(Change from baseline through post treatment (~4 weeks post baseline))
  • Trauma-Related Nightmare Survey (TRNS)(Change from baseline through 3 months post treatment)
  • Patient Health Questionnaire-9 (PHQ-9)(Change from baseline through 3 months post treatment)
  • Depressive Symptoms Index-Suicidality Subscale (DSI-SS)(Change from baseline through 3 months post treatment)
  • Self-Assessment of Sleep (SASS)(Change from baseline through 3 months post treatment)
  • Net Prompter Score(Post treatment (~4 weeks post baseline))

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Carmen McLean

Clinical Psychologist

Palo Alto Veterans Institute for Research

研究点 (2)

Loading locations...

相似试验